Durvalumab vs Fluoxetine

Durvalumab vs Fluoxetine: Overview

This comparison examines the pharmacological differences between Durvalumab and Fluoxetine.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Fluoxetine: Selective serotonin reuptake inhibitor (SSRI).

Pharmacokinetics

Half-life: Durvalumab — 17 days; Fluoxetine — 1-3 days.

Chemical Properties

Molecular Formula: Fluoxetine — C17H18F3NO.

Molecular Weight: Fluoxetine — 309.3260 g/mol.

Type: Durvalumab — Antibody; Fluoxetine — Small molecule.